Paper Details

  1. Home
  2. Paper Details

Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.

Author: JefferiesSarah, KernohanAshleigh, LawrieTheresa A, McBainCatherine, RobinsonTomos, RogozińskaEwelina

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Glioblastoma (GBM) is an aggressive brain tumor with limited treatment options after initial therapy. Research is ongoing to identify the best treatment for patients experiencing disease progression or recurrence.
Paper Details　
Original Abstract of the Article :
Glioblastoma (GBM) is a highly malignant brain tumour that almost inevitably progresses or recurs after first line standard of care. There is no consensus regarding the best treatment/s to offer people upon disease progression or recurrence. For the purposes of this review, progression and recurrenc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121043/

データ提供：米国国立医学図書館（NLM）

Treatment Options for Glioblastoma: A Network Meta-Analysis

Glioblastoma is a highly aggressive brain tumor with a challenging prognosis. This article explores the treatment options for patients experiencing progression or recurrence of glioblastoma after the initial standard of care. The authors conducted a network meta-analysis to compare different treatment options and identify the most effective strategies for managing this complex condition.

Navigating the Treatment Options for Glioblastoma

This article provides valuable insights into the current state of glioblastoma treatment, comparing various treatment options and identifying potential strategies for managing disease progression or recurrence. The authors highlight the need for further research to optimize treatment strategies and improve outcomes for patients with this challenging disease.

Think About It Like a Desert Sand Dune

Imagine a desert sand dune, shifting and unpredictable, constantly changing its landscape. Similarly, glioblastoma is a complex and challenging disease, requiring careful navigation through various treatment options to find the most effective strategy for each patient. This research aims to guide clinicians through this challenging terrain, offering insights into the best ways to manage this devastating disease.

Dr.Camel's Conclusion

This article provides a valuable overview of the current treatment landscape for glioblastoma, highlighting the need for further research to improve outcomes for patients experiencing disease progression or recurrence. The authors emphasize the importance of personalized treatment strategies tailored to each patient's specific needs and the need for ongoing research to develop more effective therapies.

Date :
  1. Date Completed 2022-03-02
  2. Date Revised 2023-11-11
Further Info :

Pubmed ID

34559423

DOI: Digital Object Identifier

PMC8121043

Related Literature

Article Analysis
・Effects of lomustine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.